AltAssets is the private equity news and research service from Almeida Capital
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

PRINT THIS PAGE

Venture capital and life sciences in Canada: A sniffle or a cold

07/08/2003Source: Macdonald & Associates.  

The amount of venture capital invested in Canadian life sciences companies fell for the third consecutive year in 2002, according to a report by Macdonald & Associates. But the life science sector's share of venture capital investment as a whole increased marginally from 17 per cent in 2001 to 19 per cent last year.

The report reveals that the Canadian life science sector has, in fact, fared better than its IT counterpart. It concludes that while the IT sector has a cold, the life science sector is merely suffering from the sniffles.

Copyright © 2003 Macdonald & Associates Limited

Click here to view full report (pdf 46.4kb)

You need Adobe Acrobat to read this document. If you do not have it, you can download it free from www.adobe.com/products/acrobat/readstep.html

For more information please contact www.canadavc.com
 

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

All rights reserved. This document and its content are for your personal, non-commercial use only. No further copying, reproduction, distribution, transmission, display of AltAssets content is allowed. To obtain permission please contact editorial@altassets.com. You may not alter or remove the copyright or any other statements from copies of the content.

AltAssets is a service offered by Almeida Capital's Research Division. Available online at www.AltAssets.net
Almeida Capital Ltd is regulated by FSA and registered in England (no. 3945728). Registered Office: Acre House, 11-15 William Road, London NW1 3ER. Legals & Terms of Use
Content is © AltAssets 2000-2008

Subscribe to our newsletter Subscribe to our newsletter